General Information of the Compound
Compound ID |
CP0424508
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(5Z)-3-[3-[4-(2,3-dichlorophenyl)piperazin-1-yl]propyl]-5-[(3,4-dimethoxyphenyl)methylidene]imidazolidine-2,4-dione
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C25H28Cl2N4O4
|
||||||||||||||||||
Molecular Weight |
519.429
|
||||||||||||||||||
Canonical SMILES |
COc1ccc(\C=C2/NC(=O)N(CCCN3CCN(CC3)c3cccc(Cl)c3Cl)C2=O)cc1OC
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C25H28Cl2N4O4/c1-34-21-8-7-17(16-22(21)35-2)15-19-24(32)31(25(33)28-19)10-4-9-29-11-13-30(14-12-29)20-6-3-5-18(26)23(20)27/h3,5-8,15-16H,4,9-14H2,1-2H3,(H,28,33)/b19-15-
Show/Hide
|
||||||||||||||||||
InChIKey |
PSZLBYHCRLTRDX-CYVLTUHYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Protein ID: PT00941, 5-hydroxytryptamine receptor 7